RxDoctor Payments Data

Carl Akin

Cardiovascular Disease · Independence, MONPI 1871598052

Payments from drug & device makers

$2,998in general payments, 2019–2025

Across 195 payments — averaging $15.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$654
  • Amgen$577
  • Sanofi-aventis U.S. LLC$266
  • Amarin Pharma, Inc.$189
  • Boehringer Ingelheim$184
  • E.r. Squibb & Sons, L.L.C.$173
  • plus $954 from 18 others

What the payments were for

  • Consulting fees$201%
  • Food & beverage$2,92898%
  • Education$502%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,998 in reported general payments places this provider in the 50th percentile of 391 cardiovascular disease providers in Missouri.

See all cardiovascular disease providers in Missouri

Other cardiovascular disease in Independence

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →